Generation of GFP reporter human induced pluripotent stem cells using AAVS1 safe harbor transcription activator-like effector nuclease

Current Protocols in Stem Cell Biology

Volumn 2014, Issue , 2014, Pages 5a.7.1-5a.7.18

  Luo, Yongquan ^a   Rao, Mahendra ^a   Zou, Jizhong ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Adeno associated virus integration site 1 (AAVS1); Gene targeting; Induced pluripotent stem cells (iPSCs); Reporter cell line; Transcription activator like effector nucleases (TALENs)

Indexed keywords

DEOXYRIBONUCLEASE I; ENHANCED GREEN FLUORESCENT PROTEIN; TRANSCRIPTION ACTIVATOR LIKE EFFECTOR NUCLEASE; DEOXYRIBONUCLEASE; GREEN FLUORESCENT PROTEIN;

ADENO ASSOCIATED VIRUS; ADENO ASSOCIATED VIRUS INTEGRATION SITE 1; ARTICLE; CARDIOMYOCYTE TRANSPLANTATION; CELL TRANSPLANTATION; DNA END JOINING REPAIR; DNA TRANSFER; GEL ELECTROPHORESIS; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOUTHERN BLOTTING; STEM CELL CULTURE; TRANSGENE; BIOSYNTHESIS; CYTOLOGY; DEPENDOPARVOVIRUS; GENETICS; INDUCED PLURIPOTENT STEM CELL; METABOLISM; REPORTER GENE; VIRUS DNA CELL DNA INTERACTION;

DEOXYRIBONUCLEASES; DEPENDOVIRUS; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; VIRUS INTEGRATION;

EID: 84924937378     PISSN: 19417322     EISSN: 19388969     Source Type: Journal    
DOI: 10.1002/9780470151808.sc05a07s29     Document Type: Article

References (17)

1. Boch, J. and Bonas, U. 2010. Xanthomonas AvrBs3 family-type III effectors: Discovery and function. Annu. Rev. Phytopathol. 48:419-436.
2. Burgess-Beusse, B., Farrell, C., Gaszner, M., Litt, M., Mutskov, V., Recillas-Targa, F., Simpson, M., West, A. and Felsenfeld, G. 2002. The insulation of genes from external enhancers and silencing chromatin. Proc. Natl. Acad. Sci. U.S.A. 99:16433-16437.
3. Deacon, T., Dinsmore, J., Costantini, L.C., Ratliff, J. and Isacson, O. 1998. Blastula-stage stem cells can differentiate into dopaminergic and serotonergic neurons after transplantation. Exp. Neurol. 149:28-41.
4. Deng, D., Yan, C., Pan, X., Mahfouz, M., Wang, J., Zhu, J.K., Shi, Y. and Yan, N. 2012. Structural basis for sequence-specific recognition of DNA by TAL effectors. Science 335:720-723.
5. Gross, D.S. and Garrard, W.T. 1988. Nuclease hypersensitive sites in chromatin. Annu. Rev. Biochem. 57:159-197.
6. Hamaguchi, I., Woods, N.B., Panagopoulos, I., Andersson, E., Mikkola, H., Fahlman, C., Zufferey, R., Carlsson, L., Trono, D. and Karlsson, S. 2000. Lentivirus vector gene expression during ES cell-derived hematopoietic development in vitro. J. Virol. 74:10778-10784.
7. Hentze, H., Graichen, R. and Colman, A. 2007. Cell therapy and the safety of embryonic stem cellderived grafts. Trends Biotechnol. 25:24-32.
8. Hockemeyer, D., Wang, H., Kiani, S., Lai, C.S., Gao, Q., Cassady, J.P., Cost, G.J., Zhang, L., Santiago, Y., Miller, J.C., Zeitler, B., Cherone, J.M., Meng, X., Hinkley, S.J., Rebar, E.J., Gregory, P.D., Urnov, F.D. and Jaenisch, R. 2011. Genetic engineering of human pluripotent cells using TALE nucleases. Nat. Biotechnol. 29:731-734.
9. Lamartina, S., Sporeno, E., Fattori, E. and Toniatti, C. 2000. Characteristics of the adenoassociated virus preintegration site in human chromosome 19: Open chromatin conformation and transcription-competent environment. J. Virol. 74:7671-7677.
10. Mak, A.N., Bradley, P., Cernadas, R.A., Bogdanove, A.J. and Stoddard, B.L. 2012. The crystal structure of TAL effector PthXo1 bound to its DNA target. Science 335:716-719.
11. Ogata, T., Kozuka, T. and Kanda, T. 2003. Identification of an insulator in AAVS1, a preferred region for integration of adeno-associated virus DNA. J. Virol. 77:9000-9007.
12. Rao, M.S. and Malik, N. 2012. Assessing iPSC reprogramming methods for their suitability in translational medicine. J. Cell Biochem. 113:3061-3068.
13. Smith, J.R., Maguire, S., Davis, L.A., Alexander, M., Yang, F., Chandran, S., Ffrench-Constant, C. and Pedersen, R.A. 2008. Robust, persistent transgene expression in human embryonic stem cells is achieved with AAVS1-targeted integration. Stem Cells 26:496-504.
14. Sun, N., Liang, J., Abil, Z. and Zhao, H. 2012. Optimized TAL effector nucleases (TALENs) for use in treatment of sickle cell disease. Mol. Biosyst. 8:1255-1263.
15. Walia, B., Satija, N., Tripathi, R.P. and Gangenahalli, G.U. 2012. Induced pluripotent stem cells: fundamentals and applications of the reprogramming process and its ramifications on regenerative medicine. Stem Cell Rev. 8:100-115.
16. Zou, J., Maeder, M.L., Mali, P., Pruett-Miller, S.M., Thibodeau-Beganny, S., Chou, B.K., Chen, G., Ye, Z., Park, I.H., Daley, G.Q., Porteus, M.H., Joung, J.K. and Cheng, L. 2009. Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells. Cell Stem Cell 5:97-110.
17. Zou, J., Sweeney, C.L., Chou, B.K., Choi, U., Pan, J., Wang, H., Dowey, S.N., Cheng, L. and Malech, H.L. 2011. Oxidase-deficient neutrophils from X-linked chronic granulomatous disease iPS cells: Functional correction by zinc finger nuclease-mediated safe harbor targeting. Blood 117:5561-5572.